Phenomenex

In Life Sciences, CEO Thomas Joyce noted a strong performance by Beckman Coulter, while in Diagnostics, he said Cepheid grew 25 percent year over year. 

The company has shut down the Veris molecular diagnostics product line, which Beckman Coulter spent years developing, as a result of its acquisition of Cepheid.

Phenomenex, a privately held manufacturer of consumables for the separation sciences, will operate as a standalone business and will retain its brand. 

The partners will co-market the Phenomenex Strata and Strata-X SPE sorbents adapted to Tecan's Freedom EVO series of robotic workstations.

MyCartis this week launched its Evaluation multiplex biomarker analysis system.
The system is intended for simultaneous analysis of multiple protein and nucleic acid markers and features an integrated reaction and detection environment, the company said.

Phenomenex this week released its Kinetex EVO C18 UPLC column. According to the company the column incorporates a patented organo-silica grafting process that utilizes uniform stabilizing ethane cross-linking" and offers high selectivity and pH stability from one to 12.

New Products: Phenomenex

Premium

Phenomenex has added 5 µm particle size to its family of Aeris PEPTIDE core-shell columns. The new column enables higher efficiencies and higher loading capability for small-scale peptide purification, the company said.

Phenomenex said that its spin-off firm, Neoteryx, has released its Mitra Microsampling Device.

NEW YORK (GenomeWeb) – Phenomenex said this week that it is spinning off a new biological samples company, Neoteryx, focused on providing microsampling products that enable simpler, less invasive, and cost-effective methods of collecting and testing biological samples.

Protein Metrics has launched top-down proteomic analysis as part of the 2.0 release of its Byonic proteomics search engine.

Pages

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.